Hospital-Acquired MRSA Infections on the Decline: Report

|

Increased awareness of practices that help prevent hospital infections, such as better hand-washing and improved patient monitoring, may be helping many facilities throughout the United States fight back against dangerous, antibiotic-resistant surgical infections. 

Scientists working with the U.S. Centers for Disease Control and Prevention (CDC) released a study in the most recent issue of the Journal of the American Medical Association (JAMA), which suggests that the number of Methicillin-resistant Staphylococcus aureus (MRSA) infections are on the decline. The sharpest decline, researchers say, appears to be in the category of invasive health care-associated MRSA.

Researchers monitored MRSA infections in nine metropolitan areas, encompassing 15 million people in the United States. From 2005 through 2008, they detected 21,503 MRSA infections, 17,508 of those, or 82%, were hospital-acquired infections. But they say those numbers have been trending downward since 2005 at an average rate of 9.4% a year. MRSA bloodstream infections showed the fastest decrease at a rate of 11.2% annually.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

According to the CDC, there are more than 2 million hospital infections acquired each year, resulting in about 90,000 deaths annually. Another 1.5 million long term care and nursing home infections occur every year.

MRSA infections, have accounted for more than 60 percent of hospital staph infections in recent years. The CDC reports that about 126,000 hospital MRSA infections occur each year, resulting in about 5,000 deaths. But some researchers suggest that the number of deaths from MRSA in the U.S. is closer to 20,000 annually.

The researchers said that the reductions they noted were likely due to increased prevention efforts in hospitals as well as U.S. healthcare workers becoming more familiar with the peculiarities of the MRSA strains prevalent in the United States, and thus knowing how to more effectively fight them and prevent further infections.

“Although these data suggest progress has occurred in preventing health care–associated MRSA infections, more challenges remain,” the researchers concluded. “Increasing adherence to existing recommendations and addressing MRSA transmission and prevention beyond inpatient settings are challenges that will require further effort and investigation if eliminating the goal of preventable health care–associated invasive MRSA infections is to be attained.”


1 Comments


Telisha
My spouse has been fighting infection and malpractice since 09-26-2009/he has been in and out of the hospital due to these infections bed sores etc only for me to find no one to assist…i ask to speak with higher mangement at UMC only for everyone to agree… Can someone please help me….I have 5 children at home on top of a very sick sick father to these children due to neglect and malpractice from umc hospital.

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation.
A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.